Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multiorgan involvement and high mortality, which was reduced because of the most widely and classically used immunosuppressive therapies. However, some patients continue to have significant mortality. So a shift in the approach to the treatment of SLE is needed. In the past decade, most transplants have been performed in the treatment of SLE with allogeneic or autologous hematopoietic stem cells and currently emerging mesenchymal stem cells. There are some important differences between the two procedures.
Miah T., Haque MA, Mahmood T., Tarafder BKClinical profile, management and outcome of lupus. Mymensingh Med J2008; 17: S6-S11.
2.
Yang W., Zhao M., Hirankarn N., et al. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum Mol Genet2009; 18: 2063-2070.
3.
Mok CC, Lau CSLupus in Hong Kong Chinese. Lupus2003; 12: 717-722.
4.
Mok CC, Tang SSIncidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus. Am J Med2004; 117: 791-795.
5.
Seligman VA, Lum RF, Olson JL, Li H., Criswell LADemographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med2002; 112: 726-729.
6.
Tikly M., Navarra SVLupus in the developing world - is it any different?Best Pract Res Clin Rheumatol2008; 22: 643-645.
7.
Heller T., Ahmed M., Siddiqqi A., Wallrauch C., Bahlas S.Systemic lupus erythematosus in Saudi Arabia: morbidity and mortality in a multiethnic population. Lupus2007; 16: 908-14.
8.
Al Arfaj AS, Khalil N.Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia . Lupus2009; 18: 465-473.
9.
Chang CC, Shih TY, Chu SJ, et al. Lupus in Chinese male: a retrospective study of 61 patients . Zhonghua Yi Xue Za Zhi (Taipei) 1995; 55: 143-150.
10.
Mok CC, Mak A., Chu WP, To CH, Wanq SNLong-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine ( Baltimore) 2005; 84: 218-224.
11.
Morton JI, Siegel BVTransplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice . Proc Natl Acad Sci USA 1974; 71: 2162-2165.
12.
Morton JI, Siegel BV, Moore RDTransplantation of autoimmune potential. II. Glomerulonephritis in lethally irradiated DBA/2 recipients of NZB bone marrow cells. Transplantation1975; 19: 464-469.
13.
Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med1994; 180: 2359-2364.
14.
Knaan-Shanzer S., Houben P., Kinwel-Bohré EP, van Bekkum DWRemission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant1991; 8: 333-338.
15.
Marmont AMStem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract Res Clin Haematol2004; 17: 223-232.
16.
Tyndall A., Saccardi R.Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol2005; 141: 1-9.
17.
Tyndall A., Gratwohl A.Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis1996; 55: 149-151.
18.
Zimmerman R. , Radhakrishan J., Valeri A., Appel G.Advances in the treatment of lupus nephritis . Ann Rev Med2001; 52: 63-68.
19.
Mageed RA, Prud’homme GJImmunopathology and the gene therapy of lupus. Gene Ther2003; 10: 861-874.
20.
Furst DEStem cell transplantation for autoimmune disease: progress and problems. Curr Opin Rheumatol2002; 14: 220-224.
21.
Marmont AM, van Lint MT, Gualandi F., Bacigalupo A.Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus1997; 6: 545-548.
22.
Marmont AM, Burt RKHematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases. Autoimmunity2008; 28: 1.
23.
Ouyang J., Sun L., Yang Y., Chen B., Han X., Fan X.A pilot study in treatment of systemic lupus erythematosus by autologous bone marrow transplant. Zhonghua Nei Ke Za Zhi2001; 40: 229-231.
24.
Wu SY, Zhao XW, Fu YW, Liu WG, Chen L., Wu Y.Effects of autologous hematopoietic stem cell transplantation on immune function in patient with systemic lupus erythematosus. Zhonggguo Shi Yan Xue Ye Xue Za Zhi2004; 12: 67-69.
25.
Li J., Zeng K., Zhou Z., et al. Safety report of autologous peripheral blood stem cell transplantation for systemic lupus erythematosus. J Clin Dermatol2007; 36: 364-366.
26.
Li J., Zeng K., Zhou Z., et al. Effect of autologous peripheral blood stem cell transplantation to life quality of systemic lupus erythematosus patients. Chin J Derm Venereol2006; 20: 84-86.
27.
Sun L., Sun J., Zeng K., et al. Alteration of autoimmune antibody in patients with systemic lupus erythematosus after autologous peripheral blood purified stem cells transplantation. Chin J Derm Venereol2009 ; 23: 6-8.
28.
Sun L., Sun J., Zeng K., et al. Changes of immune function in patients with systemic lupus erythematosus after autologous peripheral blood purified stem cells transplantation. J Dalian Med Univ2008; 30: 29-32.
29.
Fu YW, Zhu P., Zhao XW, et al. The variation of T-cell clonal repertoire in patients with systemic lupus erythematosus (SLE) following autologous peripheral blood hematopoietic stem cell transplantation. Natl Med J China2003; 83: 1648-1651.
30.
Pavletic SZTransplantation for SLE?Blood2005; 106: 2597.
31.
Kubota T.Autologous hematopoietic stem cell transplantation in SLE. Clin Rheumatol Related Res2003; 15: 26-29.
32.
Hashimoto N. , Iwasaki T., Sekiguchi M., et al. Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis. Bone Marrow Transplant2004; 33: 863-866.
33.
Tsukamoto H. , Nagafuji K., Horiuchi T., et al. A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease. Ann Rheum Dis2006; 65: 508-514.
34.
Na KS, Choi JH, Yoo DH, Kim TY, Ahn MJ, Bae SCAutologous hematopoietic stem cell transplantation in patients with refractory systemic lupus erythematosus. J Korean Rheum Assoc2003; 10: 132-140.
35.
Chng HHManagement of systemic lupus erythematosus in the coming decade: potentials and challenges. APLAR J Rheumatol2006; 9: 419-424.
36.
Tyndall A., Le Blanc K.Stem cells and rheumatology: update on adult stem cell therapy in autoimmune diseases. Arthritis Rheum2006; 55: 521-525.
37.
Le Blanc K., Ringden O.Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant2005; 11: 321-334.
38.
Sun L., Akiyama K., Zhang H., et al. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells2009; 27: 1421-1432.
39.
Zuk PA, Zhu M., Mizuno H., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng2001; 7: 211-28.
40.
Weiss ML, Troyer DLStem cells in the umbilical cord. Stem Cell Rev2006; 2: 155-162.
41.
Noort WA, Kruisselbrink AB, Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice. Exp Hematol2002; 30: 870-878.
42.
Pego-Reigosa JM, Isenberg DASystem in systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy. Expert Opin Investig Drugs2008; 17: 31-41.
Burt RK, Traynor A., Statkute L., et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA2006; 295: 527-535.
45.
Le Blanc K. , Tammik L., Sundberg B., et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol2003; 57: 11-20.
46.
Klyushnenkova E., Mosca JD, Zernetkina V., et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci2005; 12: 47-57.
Jiang X., Zhang Y., Liu B., et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood2005; 105: 4120-4126.
49.
Sotiropoulou PA, Perez SA, Gritzapis AD, et al. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells2006; 24: 74-85.
50.
Le Blanc K. , Frassoni F., Ball L., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet2004; 363: 1439-1441.
51.
Noort WA, Kruisselbrink AB, in’t Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice. Exp Hematol2002; 30: 870-878.
52.
Sun L., Zhang H., Feng X., et al. Abnormality of bone marrow-derived stem cell in patients with systemic lupus erythematosus. Lupus2007; 16: 121-128.
53.
Zhou K., Zhang H., Jin O., et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol2008; 5: 417-424.
